Qilian International Holding Group (Qilian International Holding Group) ROE % : -34.61% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Qilian International Holding Group's annualized net income for the quarter that ended in Sep. 2023 was $-16.55 Mil. Qilian International Holding Group's average Total Stockholders Equity over the quarter that ended in Sep. 2023 was $47.82 Mil. Therefore, Qilian International Holding Group's annualized ROE % for the quarter that ended in Sep. 2023 was -34.61%.

The historical rank and industry rank for Qilian International Holding Group's ROE % or its related term are showing as below:

QLI' s ROE % Range Over the Past 10 Years
Min: -16.24 Med: 12.59 Max: 38.92
Current: -15.7

During the past 7 years, Qilian International Holding Group's highest ROE % was 38.92%. The lowest was -16.24%. And the median was 12.59%.

QLI's ROE % is ranked worse than
74.93% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 4.32 vs QLI: -15.70

Qilian International Holding Group ROE % Historical Data

The historical data trend for Qilian International Holding Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group ROE % Chart

Qilian International Holding Group Annual Data

Trend

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

ROE %

Get a 7-Day Free Trial

30.28

22.02

7.79

2.00

-16.24

Qilian International Holding Group Semi-Annual Data
	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
ROE %	Get a 7-Day Free Trial								2.95	0.32	3.65	1.87	-34.61

Competitive Comparison of Qilian International Holding Group's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qilian International Holding Group's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's ROE % distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's ROE % falls into.

Qilian International Holding Group ROE % Calculation

Qilian International Holding Group's annualized ROE % for the fiscal year that ended in Sep. 2023 is calculated as

ROE %	=	Net Income (A: Sep. 2023 )	/	( (Total Stockholders Equity (A: Sep. 2022 )	+	Total Stockholders Equity (A: Sep. 2023 ))	/ count )
	=	-7.781	/	( (53.052	+	42.792)	/ 2 )
	=	-7.781	/	47.922
	=	-16.24 %

Qilian International Holding Group's annualized ROE % for the quarter that ended in Sep. 2023 is calculated as

ROE %	=	Net Income (Q: Sep. 2023 )	/	( (Total Stockholders Equity (Q: Mar. 2023 )	+	Total Stockholders Equity (Q: Sep. 2023 ))	/ count )
	=	-16.552	/	( (52.846	+	42.792)	/ 2 )
	=	-16.552	/	47.819
	=	-34.61 %

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Sep. 2023) net income data. ROE % is displayed in the 30-year financial page.

Qilian International Holding Group (NAS:QLI) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

	ROE %		(Q: Sep. 2023 )
=	Net Income	/	Total Stockholders Equity
=	-16.552	/	47.819
=	(Net Income / Revenue )	*	(Revenue / Total Assets)	*	(Total Assets / Total Stockholders Equity)
=	(-16.552 / 34.616)	*	(34.616 / 57.746)	*	(57.746 / 47.819)
=	Net Margin %	*	Asset Turnover	*	Equity Multiplier
=	-47.82 %	*	0.5995	*	1.2076
=	ROA %	*	Equity Multiplier
=	-28.67 %	*	1.2076
=	-34.61 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

	ROE %		(Q: Sep. 2023 )
=	Net Income	/	Total Stockholders Equity
=	-16.552	/	47.819
=	(Net Income / Pre-Tax Income)	*	(Pre-Tax Income / Operating Income)	*	(Operating Income / Revenue)	*	(Revenue / Total Assets)	*	(Total Assets / Total Stockholders Equity)
=	(-16.552 / -17.182)	*	(-17.182 / -5.45)	*	(-5.45 / 34.616)	*	(34.616 / 57.746)	*	(57.746 / 47.819)
=	Tax Burden	*	Interest Burden	*	Operating Margin %	*	Asset Turnover	*	Equity Multiplier
=	0.9633	*	3.1527	*	-15.74 %	*	0.5995	*	1.2076
=	-34.61 %

Note: The net income data used here is two times the semi-annual (Sep. 2023) net income data. The Revenue data used here is two times the semi-annual (Sep. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
^* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.

Qilian International Holding Group ROE % Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Qilian International Holding Group (Qilian International Holding Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » ROE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000

Website

http://ir.qlsyy.net

Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.